Yasemin Dalgali leverages an MBA from Rutgers University as a professional in the medical equipment industry. An expert in patient access and innovative medical devices, Yasemin Dalgali serves as the director at Augmenix Inc., where she is responsible for the company's overall reimbursement strategy.
A medical equipment firm, Augmenix was founded in 2007 and is headquartered in Bedford, Massachusetts. Since its founding, the firm has specialized in the development of hydrogel technology products that can be used to increase the safety of radiation applications and improve surgical procedure outcomes.
Hydrogels are a type of gel that feature a three-dimensional, polymeric network that incorporates well with water. To produce hydrogels, hydrophilic polymers are cross-linked using physical or chemical processes. Often used in contact lenses and wound care and hygiene products, hydrogels also have promising biomedical applications such as tissue engineering. This is due to their strong resemblance to living tissue and bio compatibility, as well as their ability to be produced in stable forms as well as forms that will eventually disintegrate.
